Literature DB >> 33263277

Analysis of the immune response to sciatic nerve injury identifies efferocytosis as a key mechanism of nerve debridement.

Ashley L Kalinski1, Choya Yoon1, Lucas D Huffman1,2, Patrick C Duncker3, Rafi Kohen1,2, Ryan Passino1, Hannah Hafner1, Craig Johnson1, Riki Kawaguchi4, Kevin S Carbajal3, Juan Sebastian Jara5, Edmund Hollis5,6, Daniel H Geschwind4, Benjamin M Segal7,8, Roman J Giger1,2,3.   

Abstract

Sciatic nerve crush injury triggers sterile inflammation within the distal nerve and axotomized dorsal root ganglia (DRGs). Granulocytes and pro-inflammatory Ly6Chigh monocytes infiltrate the nerve first and rapidly give way to Ly6Cnegative inflammation-resolving macrophages. In axotomized DRGs, few hematogenous leukocytes are detected and resident macrophages acquire a ramified morphology. Single-cell RNA-sequencing of injured sciatic nerve identifies five macrophage subpopulations, repair Schwann cells, and mesenchymal precursor cells. Macrophages at the nerve crush site are molecularly distinct from macrophages associated with Wallerian degeneration. In the injured nerve, macrophages 'eat' apoptotic leukocytes, a process called efferocytosis, and thereby promote an anti-inflammatory milieu. Myeloid cells in the injured nerve, but not axotomized DRGs, strongly express receptors for the cytokine GM-CSF. In GM-CSF-deficient (Csf2-/-) mice, inflammation resolution is delayed and conditioning-lesion-induced regeneration of DRG neuron central axons is abolished. Thus, carefully orchestrated inflammation resolution in the nerve is required for conditioning-lesion-induced neurorepair.
© 2020, Kalinski et al.

Entities:  

Keywords:  axon regeneration; conditioning lesion; dorsal root ganglia; efferocytosis; mouse; neuroscience; scRNA sequencing; sciatic nerve injury

Mesh:

Substances:

Year:  2020        PMID: 33263277      PMCID: PMC7735761          DOI: 10.7554/eLife.60223

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  117 in total

1.  The sva package for removing batch effects and other unwanted variation in high-throughput experiments.

Authors:  Jeffrey T Leek; W Evan Johnson; Hilary S Parker; Andrew E Jaffe; John D Storey
Journal:  Bioinformatics       Date:  2012-01-17       Impact factor: 6.937

2.  Frontline Science: Blood-circulating leukocytes fail to infiltrate the spinal cord parenchyma after spared nerve injury.

Authors:  Rafaela M Guimarães; Marcela Davoli-Ferreira; Miriam M Fonseca; Luis Eduardo A Damasceno; Flavia V Santa-Cecilia; Ricardo Kusuda; Gustavo B Menezes; Fernando Q Cunha; Jose C Alves-Filho; Thiago M Cunha
Journal:  J Leukoc Biol       Date:  2019-05-31       Impact factor: 4.962

Review 3.  The neuroimmunology of degeneration and regeneration in the peripheral nervous system.

Authors:  A DeFrancesco-Lisowitz; J A Lindborg; J P Niemi; R E Zigmond
Journal:  Neuroscience       Date:  2014-09-19       Impact factor: 3.590

4.  A Systems-Level Analysis of the Peripheral Nerve Intrinsic Axonal Growth Program.

Authors:  Vijayendran Chandran; Giovanni Coppola; Homaira Nawabi; Takao Omura; Revital Versano; Eric A Huebner; Alice Zhang; Michael Costigan; Ajay Yekkirala; Lee Barrett; Armin Blesch; Izhak Michaelevski; Jeremy Davis-Turak; Fuying Gao; Peter Langfelder; Steve Horvath; Zhigang He; Larry Benowitz; Mike Fainzilber; Mark Tuszynski; Clifford J Woolf; Daniel H Geschwind
Journal:  Neuron       Date:  2016-02-18       Impact factor: 17.173

5.  Low-density lipoprotein receptor-related protein 1 (LRP1)-dependent cell signaling promotes axonal regeneration.

Authors:  Choya Yoon; Erna A Van Niekerk; Kenneth Henry; Tetsuhiro Ishikawa; Sumihisa Orita; Mark H Tuszynski; W Marie Campana
Journal:  J Biol Chem       Date:  2013-07-18       Impact factor: 5.157

6.  Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition.

Authors:  Laurie A Robak; Karthik Venkatesh; Hakjoo Lee; Stephen J Raiker; Yuntao Duan; Jane Lee-Osbourne; Thomas Hofer; Rose G Mage; Christoph Rader; Roman J Giger
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

Review 7.  Efferocytosis in health and disease.

Authors:  Amanda C Doran; Arif Yurdagul; Ira Tabas
Journal:  Nat Rev Immunol       Date:  2019-12-10       Impact factor: 53.106

8.  PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines.

Authors:  Y-S Yoon; S-Y Kim; M-J Kim; J-H Lim; M-S Cho; J L Kang
Journal:  Mucosal Immunol       Date:  2015-01-14       Impact factor: 7.313

9.  Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics.

Authors:  Kelly Street; Davide Risso; Russell B Fletcher; Diya Das; John Ngai; Nir Yosef; Elizabeth Purdom; Sandrine Dudoit
Journal:  BMC Genomics       Date:  2018-06-19       Impact factor: 3.969

10.  Galectin-3 enhances monocyte-derived macrophage efferocytosis of apoptotic granulocytes in asthma.

Authors:  Melanie Erriah; Kavita Pabreja; Michael Fricker; Katherine J Baines; Louise E Donnelly; Johan Bylund; Anna Karlsson; Jodie L Simpson
Journal:  Respir Res       Date:  2019-01-03
View more
  15 in total

Review 1.  Biomechanical microenvironment in peripheral nerve regeneration: from pathophysiological understanding to tissue engineering development.

Authors:  Lingchi Kong; Xin Gao; Yun Qian; Wei Sun; Zhengwei You; Cunyi Fan
Journal:  Theranostics       Date:  2022-06-27       Impact factor: 11.600

2.  The primary macrophage chemokine, CCL2, is not necessary after a peripheral nerve injury for macrophage recruitment and activation or for conditioning lesion enhanced peripheral regeneration.

Authors:  Aaron D Talsma; Jon P Niemi; Joel S Pachter; Richard E Zigmond
Journal:  J Neuroinflammation       Date:  2022-07-12       Impact factor: 9.587

3.  α1-Antitrypsin derived SP16 peptide demonstrates efficacy in rodent models of acute and neuropathic pain.

Authors:  Zixuan Wang; Stefano Martellucci; Alicia Van Enoo; Dana Austin; Cohava Gelber; Wendy M Campana
Journal:  FASEB J       Date:  2022-01       Impact factor: 5.834

4.  Mature but not developing Schwann cells promote axon regeneration after peripheral nerve injury.

Authors:  Takeshi Endo; Ken Kadoya; Tomoaki Suzuki; Yuki Suzuki; Mohamad Alaa Terkawi; Daisuke Kawamura; Norimasa Iwasaki
Journal:  NPJ Regen Med       Date:  2022-01-28

Review 5.  Immunomodulatory effects of mesenchymal stem cells in peripheral nerve injury.

Authors:  Xiangling Li; Yanjun Guan; Chaochao Li; Tieyuan Zhang; Fanqi Meng; Jian Zhang; Junyang Li; Shengfeng Chen; Qi Wang; Yi Wang; Jiang Peng; Jinshu Tang
Journal:  Stem Cell Res Ther       Date:  2022-01-15       Impact factor: 6.832

6.  Tissue-resident M2 macrophages directly contact primary sensory neurons in the sensory ganglia after nerve injury.

Authors:  Haruki Iwai; Koji Ataka; Hajime Suzuki; Ashis Dhar; Eriko Kuramoto; Atsushi Yamanaka; Tetsuya Goto
Journal:  J Neuroinflammation       Date:  2021-10-13       Impact factor: 8.322

7.  Erythropoietin promotes M2 macrophage phagocytosis of Schwann cells in peripheral nerve injury.

Authors:  Prem Kumar Govindappa; John C Elfar
Journal:  Cell Death Dis       Date:  2022-03-16       Impact factor: 9.685

8.  Protocol for dissection and culture of murine dorsal root ganglia neurons to study neuropeptide release.

Authors:  Caroline Perner; Caroline L Sokol
Journal:  STAR Protoc       Date:  2021-02-08

9.  The GDF11 Promotes Nerve Regeneration After Sciatic Nerve Injury in Adult Rats by Promoting Axon Growth and Inhibiting Neuronal Apoptosis.

Authors:  Junhao Lin; Jie Shi; Xiang Min; Si Chen; Yunpeng Zhao; Yuanqiang Zhang; Lei Cheng
Journal:  Front Bioeng Biotechnol       Date:  2022-01-04

10.  Single-Cell Regulatory Network Inference and Clustering Identifies Cell-Type Specific Expression Pattern of Transcription Factors in Mouse Sciatic Nerve.

Authors:  Mingchao Li; Qing Min; Matthew C Banton; Xinpeng Dun
Journal:  Front Cell Neurosci       Date:  2021-12-08       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.